350 руб
Журнал «Технологии живых систем» №2 за 2009 г.
Статья в номере:
Gstm1: иметь или не иметь?
Ключевые слова: хромосомные аберрации полиморфизм ДНК детоксикация ксенобиотиков
Авторы:
Л.Е. Сальникова, Т.И. Иванова, Т.В. Кондрашова, Э.А. Акаева, Т.В. Елисова, И.Н. Веснина, Н.Ш. Лаптева, А.Г. Чумаченко, Г.И. Кузнецова, А.В. Рубанович
Аннотация:
Представлены две группы данных по ассоциациям нормального функционального генотипа GSTM1: 1) с заболеваниями женской репродуктивной сферы; 2) с частотой спонтанных хромосомных аберраций в лимфоцитах крови здоровых добровольцев до 25 лет. В обоих случаях мы наблюдали протективный характер действия «нулевых» генотипов GSTM1
Страницы: 31-38
Список источников
  1. Баранов В.С., Баранова Е.В., Иващенко Т.Э., Асеев М.В. Геном человека и гены «предрасположенности». Введение в предикативную медицину. СПб.: Интермедика. 2000.
  2. Сальникова Л.Е., Фомин Д.К., Елисова Т.В. и др. Изучение связи цитогенетических и эпидемиологических показателей с генотипами у ликвидаторов последствий аварии на ЧАЭС // Радиационная биология. Радиоэкология. 2008. Т.48. № 3. С. 303-312.
  3. Vogl F.D., Taioli E., Maugard C., et al. Glutathione S-transferases M1, T1, and P1 and Breast Cancer: A Pooled Analysis // Cancer Epidemiol Biomarkers Prev. 2004. Vol. 13(9).
  4. da Fonte L.A., Rossini A., Mendonca G., et al. CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women // Cancer Lett. 2002. Vol. 181. P. 179-186.
  5. Zheng W., Wen W.Q., Gustafson D.R., et al. GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk // Breast Cancer Res. Treat. 2002. Vol. 74. P. 9 - 16.
  6. Siraj A.K., Ibrahim M., Al-Rasheed M., et al. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population // BMC Med. Genet. 2008. V.9. V.61.
  7. Raimondi S., Boffetta P., Anttila S., et al. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study // Mutat. Res. 2005. V. 592. N. 1-2. P. 45 - 57.
  8. Marcon F., Andreoli C., Rossi S., et al. Assessment of individual sensitivity to ionizing radiation and DNA repair efficiency in a healthy population // Mutat. Res. 2003. V. 541. N. 1-2. P. 1 -8.
  9. Iarmarcovai G., Sari-Minodier I., Orsiere T., et al. Acombined analysis of XRCC1, XRCC3, GSTM1 and GSTT1polymorphisms and centromere content of micronuclei in welders // Mutagenesis. 2006. V. 21. N. 2. P.159 - 165.
  10. Gago-Dominguez M., Jiang X. Castelao J.E. Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis // Breast Cancer Research. 2007. V. 9. P. 201.
  11. Brennan P., Hsu C.C. , Moullan N., et al. Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach // The Lancet. 2005.  V. 366. P. 1558-1560.
  12. Gaudet M.M., Olshan A.F., Poole C., et al. Diet, GSTM1 and GSTT1 and head and neck cancer // Carcinogenesis. 2004. Vol. 25. N. 5. P. 735-740.
  13. Palli D., Masala G., Peluso M., et al. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects // Carcinogenesis. 2004. Vol. 25. N. 4. P. 577-584.
  14. Reszka E., Wasowicz W., Gromadzinska J. Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility // Br. J. Nutr. 2006. V. 96. N. 4. P. 609-619.
  15. Tseng E., Scott-Ramsay E.A., Morris M.E. Dietary organic isothiocyanates are cytotoxic in human breast cancer MCF-7 and mammary epithelial MCF-12A cell lines // Exp. Biol. Med. 2004.  V. 229. P. 835-842.
  16. Sorensen M., Raaschou-Nielsena O., Brasch-Andersenb C., et al. Interactions between GSTM1, GSTT1 and GSTP1polymorphisms and smoking and intake of fruit and vegetables in relation to lung cancer // Lung Cancer. 2007. V. 55. P. 137-144.
  17. Patent № 0060194200 (US).
  18. Roodi N., Dupont W.D., Moore J.H., et al. Association of homozygous wild-type glutathione S-trans­ferase M1 genotype with increased breast cancer risk // Cancer Res. 2004. V. 64. P. 1233-1236.
  19. Godschalk R.W., Ostertag J.U., Zandsteeg A.M., et al. Impact of GSTM1 on aromatic-DNA adducts and p53 accumulation in human skin and lymphocytes // Pharmacogenetics. 2001. V.11. N. 6. P. 537-543.
  20. Song J.J., Lee Y.J. Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1 // Biochem. J., 2003. V. 373.  P. 845-853.
  21. Dorion S., Lambert H., Landry J. Activation of the 38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1 // The Journal of Biological Chemistry. 2002. V. 277. N. 34. P. 30792-30797.
  22. Hayes J.D., Strange R.C. Glutathione S-Transferase polymorphisms and their biological consequences // Pharmacology. 2000. V. 61. P. 154-166.
  23. Kirsch-Volders M., Mateuca R. A., Roelants M., et al. The Effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivo // Cancer Epidemiol Biomarkers Prev. 2006. V. 15. P. 1038-1042.
  24. Reszka E., Wasowicz W., Gromadzinska J. Antioxidant defense markers modulated by glutathione S-transferase genetic polymorphism: results of lung cancer case-control study // Genes Nutr. 2007. V. 2. P. 287-294.
  25. Shi-jie Xu, Ying-ping Wang, B. Roe, Pearson W.R. Characterization of the Human Class Mu Glutathione S-Transferase Gene Cluster and the GSTM1 Deletion // Journal of Biological Chemistry. 1998. V. 273. N. 6. P. 3517-3527.
  26. Ye Z., Song H., Higgins J. P. T., et al. Five glutathione S-transferase genevariants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies // PLoS Medicine. 2006. V. 3. Issue 4. P. 91.
  27. Houlston R. S. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis // Cancer Epidemiology, Biomarkers & Prevention. 1999. V. 8. P. 675-682.
  28. Dunning A. M., Healey C. S., Pharoah P. D. P., et al. A systematic review of genetic polymorphisms and breast cancer risk // Biomarkers & Prevention. 1999. V. 8. P. 843-854.